Inj, vancomycin (mylan) 10mg
Products billed under this code include Vancomycin HCl.
Payment limit per 10 MG, by effective quarter, 3Q25 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J3374
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9152-10 | 1250 | $113.75 |
| Vancomycin HCl | Hikma Pharmaceuticals USA Inc. | 00143-9153-10 | 1500 | $136.50 |
| Vancomycin HCl | Sagent Pharmaceuticals | 25021-0147-20 | 750 | $68.25 |
| Vancomycin HCl | Sagent Pharmaceuticals | 25021-0148-30 | 1250 | $113.75 |
| Vancomycin HCl | Sagent Pharmaceuticals | 25021-0149-30 | 1500 | $136.50 |
| Vancomycin HCl | XGen Pharmaceuticals DJB, Inc. | 39822-0460-02 | 1250 | $113.75 |
| Vancomycin HCl | XGen Pharmaceuticals DJB, Inc. | 39822-0470-02 | 1500 | $136.50 |
| Vancomycin HCl | Eugia US LLC | 55150-0471-10 | 1250 | $113.75 |
| Vancomycin HCl | Eugia US LLC | 55150-0472-10 | 1500 | $136.50 |
| Vancomycin HCl | Mylan Institutional LLC | 67457-0705-75 | 750 | $68.25 |
Show all 17 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Vancomycin HCl | Mylan Institutional LLC | 67457-0823-99 | 1250 | $113.75 |
| Vancomycin HCl | Mylan Institutional LLC | 67457-0824-99 | 1500 | $136.50 |
| Vancomycin HCl | Glenmark Pharmaceuticals Inc., USA | 68462-0477-74 | 750 | $68.25 |
| Vancomycin HCl | Glenmark Pharmaceuticals Inc., USA | 68462-0478-84 | 1250 | $113.75 |
| Vancomycin HCl | Glenmark Pharmaceuticals Inc., USA | 68462-0479-84 | 1500 | $136.50 |
| Vancomycin HCl | Mylan Institutional LLC | 72078-0065-99 | 1750 | $159.25 |
| Vancomycin HCl | Mylan Institutional LLC | 72078-0066-99 | 2000 | $182.00 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.091 | −$0.006 | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted September 17, 2026 |
| 3Q26 | $0.097 | −$0.001 | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted September 15, 2026 |
| 2Q26 | $0.098 | −$0.005 | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted September 15, 2026 |
| 1Q26 | $0.103 | −$0.012 | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted September 15, 2026 |
| 4Q25 | $0.115 | −$0.006 | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted September 8, 2026 |
| 3Q25 | $0.121 | – | 10 MG | Inj, vancomycin (mylan) 10mg | v1, posted March 10, 2026 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026